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Abstract: 
 
Analysis of complex mixtures is a common challenge in natural products research. Quantitative 
nuclear magnetic resonance spectroscopy offers analysis of complex mixtures at early stages and 
with benefits that are orthogonal to more common methods of quantitation, including ultraviolet 
absorption spectroscopy and mass spectrometry. Several experiments were conducted to 
construct a methodology for use in analysis of extracts of fungal cultures. A broadly applicable 
method was sought for analysis of both pure and complex samples through use of an externally 
calibrated method. This method has the benefit of not contaminating valuable samples with the 
calibrant, and it passed scrutiny for line fitting and reproducibility. The method was implemented 
to measure the yield of griseofulvin and dechlorogriseofulvin from three fungal isolates. An 
isolate of Xylaria cubensis (coded MSX48662) was found to biosynthesize griseofulvin in the 
greatest yield, 149 ± 8 mg per fermentation, and was selected for further supply experiments.  
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Article: 
 
Introduction 
 
When using fungi as a source for drug discovery, pure compounds are often isolated in quantities 
of 1.0 mg or less. Although structure elucidation via nuclear magnetic resonance (NMR) can be 
accomplished on this scale, this amount is quickly consumed through biological testing and other 
experimentation. This valuable compound may then require resupply through the fermentation of 
new batches of the fungal culture. In order to expedite future restocking, several organisms and 
media optimization studies may be tested to find the most productive organism and conditions 
for the resupply of the analyte of interest.1-5 
 
The key challenge then falls to analysis of the samples. There are many ways that one could 
employ to analyze the various fermentations. Historically, analysis of resupply conditions re‐
isolated the compound of interest, so as to quantitate the yield under new conditions.2 However, 
this process can be time intensive, impeding further research on promising leads. Recent 
innovations in mass spectrometry (MS), particularly ambient ionization techniques like 
LAESI,6 DESI,7 and MALDI,8 or surface sampling probes like droplet–liquid microjunction–
surface sampling probe,9, 10 continuous flow–liquid microjunction–surface sampling probe,11 and 
liquid extraction surface analysis12 have drastically reduced the analysis time. These techniques 
can provide an in situ snapshot of the metabolite profile of a culture's surface. However, 
quantitative information is difficult to derive from these techniques without further study. They 
are also incumbent upon the ionization properties of the metabolites. Liquid chromatography 
(LC)–MS analysis of the extract can be used to quantify the results,13 but this requires the use of 
a reference standard of the analyte for calibration of ionization efficiency and creation of a 
standard curve. This is often not feasible if the residual pure sample after early experimentation 
is extremely low. Without calibration, LC–MS can only be used to give relative production of 
compounds of interest, and while that may provide a picture of the relative biosynthesis, it can be 
useful to acquire quantitative information to further evaluate the productivity of the fermentation 
conditions. 
 
Quantitative NMR (qNMR) spectroscopy is a validated method14 that can be used to quantify 
and analyze secondary metabolites upstream in the isolation and purification process. Aside from 
its non‐destructive nature, qNMR offers several benefits over LC–MS. Quantitation does not 
necessitate a purified standard of the analyte to calculate a standard curve.15 Additionally, NMR 
spectroscopy inherently contains some separation of constituent signals,15 such that complex 
samples can be analyzed upstream of relatively pure samples in a way that is orthogonal to LC–
MS or LC‐ultraviolet quantitation. With these benefits, qNMR can be applied early in an 
isolation process, providing quantitative measurements with which to compare differing culture 
conditions. Moreover, because NMR is frequently incorporated into natural products research 
schemes,16-24 this process does not necessitate acquisition of new equipment or severe deviation 
in protocols. The end result is the selection of an efficient fungal strain and/or specific 
fermentation conditions to resupply valuable compounds extrapolated from the quantitative 
information. 
 
Griseofulvin 
 
Three fungal isolates were evaluated for the biosynthesis of secondary metabolites, with the goal 
of determining the best culture for their large‐scale production. Griseofulvin (1) and 
dechlorogriseofulvin (2) (Figs 1, S1, S2 and S4) were observed in extracts of three separate 
isolates of Xylaria cubensis, which were coded MSX54665, MSX48662, and G536.25 Originally 
isolated from a filamentous fungus in 1939,26 compound 1 was one of the first antifungal 
compounds isolated from a natural product source and has been in the market for the treatment of 
several dermatological fungal infections in animals and humans.27-29 The recent literature 
on 1 for activity against cancer and suppression of hepatitis C virus replication, in conjunction 
with the influx of patents for analogues of 1, indicate the expanding interest in this class of 
compounds.30-33 Production of 1 is well established via industrial fermentation processes.34-
36 Our interest was to examine cultures that biosynthesize 1 for two complementary reasons. As 
described herein, it made a good test case for the use of qNMR for profiling biosynthesis. 
Moreover, as will be reported in the future, in the context of a program to discover new 
anticancer drug leads from fungal cultures,37 we needed to enhance the supply of 1 and related 
analogues for a series of semisynthetic experiments. 
 
 
Figure 1. Structures of compounds 1–3. 
 
Experimental Section 
 
Fungal strains and identification 
 
Fungal strain MSX48662 was isolated from cedar wood collected in Little Rock, Arkansas, in 
May of 1990, while MSX54665 was isolated from leaf litter obtained in Wilson County, 
Tennessee, in April of 1991. Fungal strain G536 was isolated from surface sterilized twigs of 
pawpaw (Asimina triloba (L.) Dunal, Annonaceae) collected from Pfafftown, North Carolina, 
USA as described in detail previously.25 
 
The fungal strains were identified via morphological and molecular methods, and the 
identification of strain G536 has been described in detail25; the sequence data for G536 were 
deposited in the GenBank (KU560914, KU560915, KU560916). Fungal strains MSX48662 and 
MSX54665 were characterized using molecular sequence data from nuclear ribosomal internal 
transcribed spacers and 5.8S gene (nuc ITS), and approximately 600 base pairs of the adjacent 
D1/D2 regions of the nuclear ribosomal large subunit (nuc LSU) were amplified using methods 
described earlier.38-42 Molecular characterization of strain G536 suggests that the fungus belongs 
to X. cubensis.25 BLAST search via GenBank showed high coverage and percent identity values 
with several sequences of X. cubensis, Sordariomycetes, Ascomycota.43, 44 All sequences with 
high similarity to the BLAST search were downloaded from GenBank and incorporated into a 
multiple sequence alignment and subjected to a maximum likelihood (ML) phylogenetic 
analysis45 using RAxML. Results of the ML analysis showed that both MSX strains are nested 
with numerous X. cubensis strains, including authentic sequences GU991523 and AB625440, 
which have been utilized in molecular phylogenetics of Xylaria spp.46 (Fig. S5). The sequence 
data were deposited in GenBank (MSX48662: KX229783; MSX54665:KX229784). 
 
Extraction 
 
Separately, solid‐substrate fermentations of the three fungi (Fig. 2) were chopped with a spatula 
and shaken for 16 h at 100 rpm with 500‐ml MeOH/CHCl3 in a 1:1 mixture. The supernatants 
were collected via vacuum filtration, and solid substrates were washed with 100 ml of 1:1 
MeOH/CHCl3. To the filtrates, 900‐ml CHCl3 and 1500‐ml H2O were added followed by 2 h of 
stirring. The mixtures were transferred to separatory funnels, and the two layers were drawn off 
into independent flasks. The bottom layers were evaporated to dryness under vacuum and 
reconstituted in 300 ml of 1:1 MeOH/CH3CN and 300 ml of hexanes. These solutions were 
transferred back to separatory funnels and shaken vigorously. The MeOH/CH3CN layers 
(hereafter referred to as organic extract) were evaporated to dryness under vacuum. 
 
 
Figure 2. Solid substrate fermentations of MSX54665, G536, and MSX48662. 
 
Sample preparation 
 
Organic extracts were reconstituted in DMSO‐d6 at 2.0 mg/ml for MSX48662, 5.0 mg/ml for 
G536, and 10 mg/ml for MSX54655. The samples were weighed on a micro‐analytical balance 
(XS105, Mettler Toledo), with precision of ±0.01 mg. DMSO‐d6 99.9% (Lot #: PR‐
26893/10075DM1) was purchased from Cambridge Isotope Laboratories. Chrysophanol (3) 
(Figs 1 and S3) (99.3% Lot No. 870622; Madaus, Germany) was used as a calibrant and was 
reconstituted using DMSO‐d6 at 0.50 mg/ml. All reconstituted fungal extracts were prepared in 
single stocks and then transferred in triplicate aliquots of 0.50 ml into standard 5‐mm NMR 
tubes. 
 
Quantitative NMR 
 
Quantitative NMR measurements were conducted on a JEOL ECA‐500, operating at 500 MHz 
for 1H and 125 MHz for 13C using parameters recommended in literature.15 For each set of 6 to 
12 samples, auto‐tuning was employed to optimize the probe. The autogain program routine was 
then run on the first sample in a preliminary experiment to establish an optimal gain value. Each 
sample was then set to 90% of the optimal gain value so as to maximize signal while avoiding 
clipping. A 60‐s relaxation delay was incorporated to ensure relaxation of most protons. Two 
dummy scans were applied to achieve steady state for each sample, and those were followed by 
eight scans. A 90° pulse was applied to give maximum detector response. Acquisition time was 
set to 3 s, and a 20‐ppm spectral width was used, centered on 6.5 ppm. Sample temperature was 
maintained at 25°C. 
 
 
Figure 3. Selected sections of the 1H NMR spectra of MSX54665, G536, and MSX48662 at 
2.0 mg/ml in DMSO‐d6. Given are the sections useful for quantitation of the methoxy groups. 
The DMSO‐d5peak is also included for comparison. Spectra were collected on a JEOL ECA‐500 
operating at 500 MHz with two dummy scans followed by eight scans. 
 
NMR files were processed using MestReNova software (Mestrelab Research, S.L.). Exponential 
apodization was applied using a value of 0.40 Hz, followed by phase correction. The baseline of 
each spectrum was corrected using the Whittaker Smoother routine included in the MestReNova 
software. The chemical shift was then adjusted to the DMSO‐d5peak, which was set to 
2.500 ppm. Analyte peaks used in quantitation were selected based on high intensity and relative 
isolation from neighboring peaks. Based on a close inspection of peak shape, peaks were selected 
if the majority of peak area was due to the analyte signal, rather than neighboring peaks. Peaks 
that did not pass this scrutiny were also excluded from use for quantitation. Integration was then 
applied in a manner to exclude neighboring peaks. In the standard, and where possible in the 
analyte samples, integration was taken for a spectral width of 30 Hz. The solvent peak was 
integrated identically between the standard and analyte samples to ensure consistent integration 
and then was normalized to an arbitrary large value (i.e. 10 000.00). By setting the solvent peak 
to a large value, the relatively small analyte and standard integrals were comparable, so as to 
give a sense of variation of the concentrations in the samples. 13C satellites were visible for the 
solvent peak but were not included in integration or purity calculations. Complete spectra and the 
assignment of peaks for 1 and 2 are included in the supplementary data (Figs S1, S2, and S4) and 
have been reported.47 
 
 
 
Figure 4. Selected sections of the 1H NMR spectra of MSX54665, G536, and MSX48662 at 10, 
5.0, and 2.0 mg/ml, respectively, in DMSO‐d6. Given are the sections useful for quantitation of 
the methoxy groups. The DMSO‐d5 peak is also included for comparison. Peak height of spectra 
was normalized to the DMSO‐d5 peak. Spectra were collected on a JEOL ECA‐500, operating at 
500 MHz with two dummy scans followed by eight scans. 
 
Results and Discussion 
 
Three separate fungal cultures were observed to biosynthesize griseofulvin (1) and 
dechlorogriseofulvin (2). The goal of this study was to determine which isolate produced 
compounds 1 and 2 in the greatest yield. The intensity of the analyte signals for MSX48662 was 
high enough to generate meaningful quantitative results at the initial concentration of 2.0 mg/ml. 
However, the organic extracts of MSX54665 and G536 dissolved at 2.0 mg/ml had low signal 
intensity of 1 and 2 with S/N ratios ranging from 40 to 80 (Fig. 3), which were not ideal for 
quantitation.14, 15, 48 In general, low S/N can hinder the ability to detect small impurities in the 
baseline surrounding analyte peaks.15 The low S/N was seen to affect baseline correction and 
integration of analyte peaks, thereby introducing error into quantitation. Additionally, a high 
noise level can cause overcompensation of automatic baseline correction routines, which can 
skew integration downward. Minor impurities were likely to be hidden by noise if their low 
concentration does not permit their detection, due to the complexity of the spectral region of 
interest. To compensate for the low signal, the samples of MSX54665 and G536 were 
concentrated to 10 and 5 mg/ml, respectively, to yield higher peak intensity. Subsequently, the 
NMR experiments were repeated to yield S/N ratio ranging from 120 to 240 for analyte peaks 
(Fig. 4). 
 
Purity Calculation 
 
To calculate purity and yield of 1 and 2 from the various fungal cultures, the following formula 
was applied, where mx is the calculated mass of analyte, 1 or 2, inside of the sample mixture, 
mcal is the measured mass of calibrant in the prepared calibrant sample, Sx is the normalized 
integral of the analyte, Scal is the normalized integral of the calibrant, Ncal is the number of 
protons represented by calibrant peak, Nx is the number of protons represented by the peak of the 
analyte, Mx is the molar mass of the analyte, and Mcal is the molar mass of the calibrant. 
 
 
(1) 
 
In this project, the contents of 1 and 2 within the three fungal extracts were measured, and 3was 
used as a calibrant. Simple analyte integrals were normalized to the solvent signal, so as to 
compensate for variation in integrals due to any dilution effect from contaminants (i.e. water), 
any signal variation between NMR tubes, or sample shimming in the magnet. As noted by 
Krunic and Orjala,49 using a single batch of DMSO‐d6 gave the best consistency of DMSO‐
d5 concentration and corresponding consistency of raw integrals of the DMSO‐d5peaks. 
 
Sample mass was then used to calculate purity of the sample using the following equation: 
 
 (2) 
 
where mx is the sample mass as in Eqn 1, Vsmp is the total volume used in the NMR experiment, 
and Csmp is the concentration of sample inside the tube (Table 1 and Fig. S6). Purity was then 
extrapolated to the extract to yield a calculated mass of analyte (mtot x) (Table 2) that was 
produced by the fungal strain using the equation: 
 
 (3) 
 
where mtot corresponds to the mass of the organic extract. 
 
Result of Extract Comparison 
 
Culture MSX48662 had the highest total yield of 1 and 2 (149 ± 8 mg per fermentation and 
102 ± 2 mg per fermentation, respectively) (Table 2 and Fig. S6). In contrast, culture MSX54665 
yielded 5.4 ± 0.3 mg of 1 per fermentation, and G536 yielded 4.6 ± 0.1 mg of 1and 2.6 ± 0.2 mg 
of 2 per fermentation. These results suggested that MSX48662 would be the best of the three 
candidate fungal cultures for the resupply of compounds 1 and 2. 
 
Table 1. Purity of 1 and 2 in fungal extracts 
Culture Compound 1 Compound 2 
Purity SD CV Purity SD CV 
MSX54665 0.0055 0.0003 5.8% N/D N/A N/A 
G536 0.0164 0.0005 3.3% 0.0095 0.0007 7.3% 
MSX48662 0.076 0.004 5.0% 0.052 0.001 2.7% 
Included are the results from one qNMR experiment. Each extract sample was weighed and aliquoted into 
triplicate NMR tubes and compared to a single triplicate set of standard. Purity represents a proportion of 
analyte in the extract; SD = standard deviation; CV = coefficient of variation. 
 
Table 2. Mass of 1 and 2 in fungal extracts 
Culture Compound 1 Compound 2 
Mass (mg) SD (mg) CV Mass (mg) SD (mg) CV 
MSX54665 5.4 0.3 5.8% N/D N/A N/A 
G536 4.6 0.1 3.3% 2.6 0.2 7.3% 
MSX48662 149 8 5.0% 102 2 2.7% 
Total mass of 1 and 2 in each organic extract are shown. Signals of 2 were not readily identifiable in the 
extract of MSX54665 and thereby mass of 2 was not calculated. 
 
Challenges in Analysis 
 
qNMR of complex mixtures suffers from signal overlap and requires careful consideration of 
solvent and instrumentation to give the best possible isolation of quantifiable peaks. During 
analysis, MSX54665 displayed numerous signals between 3.8 and 4.1 ppm, which had a similar 
shape to methoxy signals observed for both 1 and 2. While these signals could indicate a number 
of griseofulvin analogues, which could be interesting from a research standpoint, the signals did 
not have baseline resolution between neighboring peaks. At the 10 mg/ml concentration of the 
organic extract of MSX54665, the methoxy peaks of compound 2 were not readily identifiable 
within this population of signals and were therefore not calculated (Tables 1 and 2, Figs 4 and 
S6). 
 
In the organic extracts of MSX48662 and G536, the 6‐OMe signal of 1 and 2 had subtle 
shoulders that indicated peaks with little separation from the analyte peaks. Although the 4‐OMe 
had similar contaminant signals, the peaks were better resolved. To determine the effect of the 
neighboring signals on the 4‐OMe signals used for quantitation, contaminant and analyte peaks 
were fitted using line fitting procedures included in the MestReNova software. Peaks were fitted 
using the automated ‘fit’ routine in combination with manual adjustments to yield even residual 
noise, once all differentiable peaks were modeled. The side peaks were labeled as impurities, and 
integrals were recalculated using the EditedSum integration routine, which subtracts modeled 
peak areas of impurities from the measured integrals. Thereby, the analyte peaks were well 
represented by the resulting integral. The peak fitting integration (Fig. S7) for the extracts of 
MSX54665 and MSX48662 reflected the original calculations well and yielded notably 
improved standard deviations. For the extract of G536, overlapping contaminant peaks formed a 
faux baseline around the analyte peaks, and these interfered with the software's fitting routines. 
As the routines would try to explain a multitude of poorly defined contaminant peaks, peak 
models were ‘over‐fitted’ to the data. Because the peak fittings of the better resolved spectra 
correlated well with the raw integrations and purity calculations, the previous method was 
deemed acceptable for the calculation of analyte purity. However, a peak fitting method may be 
preferable, and close inspection of data is required to determine the benefit of peak modeling. 
 
2D qNMR has been used to deconvolute complex samples as well. These 2D methods can 
require advanced digital or mathematical manipulation of peaks to ensure accurate quantitation. 
2D methods have seen improvements on long acquisition times through optimization techniques, 
such as J‐resolved and DQF‐COSY,50, 51 which have reduced the impact of acquisition time on 
the accuracy of their measurements. Although such methods may help in the deconvolution of 
the complex peaks, the high sensitivity, short acquisition time, and the relative ease of 
chromatographic sample purification give good reasons to use 1D 1H NMR as the basis for a 
general method for analysis of small molecules, at least with respect to natural products research. 
 
Reproducibility 
 
Chrysophanol (3) was chosen as a calibrant due to its availability and to maximize 
reproducibility of the experiments. As 3 is a solid at room temperature, the concentration of 
calibrant should remain constant relative to the slowly evaporating DMSO solvent, even over 
long periods of time. The volatility of 3 is contrast to calibrants used in internal calibration 
methods, like dichloromethane, which readily evaporate and are thereby advantageous for the 
simplicity of analyte recovery but may not remain constant over a long period of time. Although 
the stability was only tested over a period of three days, using a nonvolatile calibrant served to 
remove variability due to volatility from the measurements. This could allow for repeated 
measurements of these samples over extended periods of time, in this case likely being limited 
by signal contamination from water introduction to the DMSO. Other calibrants suggested by 
Pauli and Rundlöf include DMSO, caffeine, and 3‐sulfolene as well as other compounds with a 
range of resonances to suit various applications.15, 52 
 
The reproducibility of the measurements was established through three replicate analyses of the 
purity of MSX48662. Triplicate aliquots were made of a sample of 3 (Figs S3 and S4) at 
0.50 mg/ml and the extract of MSX48662 at 2.0 mg/ml. The latter aliquots were analyzed using 
the above method for content of 1. The calculations were averaged to give purity and standard 
deviation. To determine the precision of the measurement, this process was completed twice 
more, each on separate days to account for multi‐day variability, including weighing and 
dissolving new batches of sample extract and calibrant (Table 3, Fig. S6). The average purity 
calculated from three days of the experiment was 7.4 ± 0.5% (Table 3, Fig. S6). The standard 
deviation was less on several of the individual days than for the average of all days. To estimate 
multi‐day variability of the NMR spectrometer and post‐collection processes, a single set of 
triplicate standards and analytes from MSX48662 were processed through the above qNMR 
analysis over three days (Table 4, Fig. S6). The average purity from the one set of triplicates was 
7.7 ± 0.3%. The coefficient of variation dropped from 7.1% variation among the complete 
replicates to 4.0% among the replicate measurements of a single set of replicates. 
 
Table 3. Complete repetition of method on MSX48662 extract 
Repetition Compound 1 Compound 2 
Purity SD CV Purity SD CV 
1 0.076 0.004 5.0% 0.052 0.001 2.7% 
2 0.078 0.006 7.6% 0.055 0.005 8.2% 
3 0.069 0.002 3.5% 0.048 0.002 4.4% 
Tot. 0.074 0.005 7.1% 0.051 0.004 7.5% 
Each repetition was made from a separate weighing of MSX48662, separated into three aliquots. Each 
repetition represents a complete set of sample triplicates and calibrant triplicates. Each repetition was 
completed on a separate day to include multi‐day variation. 
 
Table 4. Analysis of single MSX48662 extract triplicate 
Day Compound 1 Compound 2 
Purity SD CV Purity SD CV 
1 0.076 0.004 5.0% 0.052 0.001 2.7% 
2 0.076 0.002 2.0% 0.054 0.002 3.3% 
3 0.081 0.001 1.5% 0.056 0.001 1.3% 
Tot. 0.077 0.003 4.0% 0.054 0.002 4.0% 
A single weighing of MSX48662 extract was separated into three aliquots. This set of triplicate samples 
was measured over 3 days. The results imply that variation due to the day‐to‐day drift of the NMR 
spectrometer is small compared to other factors. 
 
Previous literature has described the use of a solvent signal that is calibrated externally for 
quantification.15 Using this method allows the sample to remain untainted from introduction of a 
calibrant into a valuable sample, but it requires careful weighing and pipetting. The smaller 
variability between days using the same sample, and the higher variability between separate 
samples on separate days, was taken to indicate that the majority of the error involved in the 
analysis occurs in the weighing and pipetting. 
 
Applicability 
 
Use of this method gave clear indication that MSX48662 biosynthesized the largest amounts 
of 1 and 2 per fermentation. This technique could be used to analyze separate growth conditions 
as well, because it is well documented that different growth conditions produce varying 
metabolite profiles.1 Additionally, because we have chosen to use a method that does not require 
any internal calibrant, the contamination of the analyte is not a concern. Thereby, this method 
also lends itself to use for purified samples, as it is unnecessary to complete further purification 
steps to recover the measured material. In particular, this method should be useful for novel 
compounds for which analytical reference standards are not available. This method could also be 
used to verify reference standards before their use for quantitation in other methods. Applications 
could include forensic science of novel designer drugs, where new illicit drugs often have no 
standards available.53 As a starting point, this general method allows for the analysis of small 
molecules produced from natural products research. Techniques like 2D NMR, spectral 
deconvolution, 13C decoupling, or chromatographic methods can be employed subsequently to 
overcome the predominant drawback of this method, which may be its inability to overcome 
extensive signal overlap. Somewhat redeeming is that a single, relatively pure signal from a 
nonexchangeable proton is sufficient to quantify a compound using the described method.15 
 
Although the method outlined above utilizes common instrumentation and equipment, 
supplemental NMR and chromatographic instrumentation and techniques were observed to 
further assist in the quantitation procedures. Flash chromatography of extracts can enhance the 
purity of the analytes 1 and 2, and simplify the spectrographic complexity within a few hours of 
work (Fig. S8). Additionally, S/N could be improved with use of a greater number of scans,15 
with reduced volume NMR tubes,49 or with the use of a modern cryoprobe (Fig. S8).48, 49 
Moreover, minor impurities could be revealed if a higher magnetic field was used to increase 
spectral resolution, thereby separating closely shifted peaks.48 For this study, an increase in 
resolution by using a higher magnetic field, or use of deconvolution methods, could help to 
elucidate the signals of 2 in the extract from MSX54665.54 In efforts to make the method 
generally applicable, however, standard instrumentation and a shorter timeframe were 
emphasized. Therefore, concentrations of the two extracts with low analyte signal were increased 
to give the desired S/N, and the method yielded comparative results with eight scans, requiring 
10 min of collection per sample. 
 
Conclusion 
 
In natural products research, the world's supply of a promising compound can be rapidly 
consumed in follow‐up bioassay studies. Analysis of the experiments designed to efficiently 
resupply these compounds can be challenging without a well‐characterized reference sample. 
NMR has the ability to quantitate any proton, even in the absence of a reference standard. 
Thereby, nearly any secondary metabolite can be measured using this method. In this study, 
MSX48662 yielded the most of the target compounds and was therefore the best of the three X. 
cubensis isolates to supply griseofulvin (1) and dechlorogriseofulvin (2) for further 
experimentation. The use of a qNMR method afforded an orthogonal measurement to LC–MS 
of 1 and 2 within extracts. 
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